The specificity of DT-061 to a single member of the B56 family illustrates that small molecules can be used to selectively stabilize specific PP2A holoenzymes and highlights that PP2A activity can be redirected toward more tumor suppressive substrates. The gene discussed is PTPA; the disease is neoplasm.